Spectrum from common postpartum blues to severe depression and rare psychosis.
Also known as: postpartum depression, PPD, postpartum psychosis, perinatal depression, baby blues
Overview
Postpartum blues: transient, mild mood symptoms in the first 2 weeks postpartum, self-limited. Postpartum (perinatal) depression: a major depressive episode with onset during pregnancy or within 12 months postpartum, lasting >=2 weeks. Postpartum psychosis: a psychiatric emergency with delusions, hallucinations, disorganized behavior, or severe mood disturbance, usually within 4 weeks of delivery.
Epidemiology
Postpartum blues: up to 80% of postpartum women. PPD: 10-15% of postpartum women. Postpartum psychosis: 1-2 per 1000 deliveries; markedly increased risk in women with bipolar disorder (up to 25-50%).
Try two board-style Postpartum Depression and Postpartum Psychosis questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1PsychiatryMedium
A 32-year-old female 2 weeks postpartum presents with insomnia, agitation, paranoid delusions about the baby being possessed, and disorganized thinking. Which of the following is the most likely diagnosis?
APostpartum anxiety
BPostpartum psychosis
CPostpartum blues
DPostpartum hypomania
EPostpartum depression
Reveal answer & full explanation
Correct answer: B — Postpartum psychosis
APostpartum anxiety
BPostpartum psychosis✓
CPostpartum blues
DPostpartum hypomania
EPostpartum depression
Why Postpartum psychosis is correct
Onset within the first 2 weeks postpartum
Symptoms include hallucinations, delusions (often about the baby), severe mood changes, and disorganized thinking
Risk of infanticide is 4% and suicide is 5%, making this a psychiatric emergency requiring mandatory hospitalization
Often represents the first manifestation of bipolar disorder
Treatment: mood stabilizer plus antipsychotic; electroconvulsive therapy (ECT) for severe or refractory cases
Why the others are wrong
Postpartum depression — longer duration, no psychosis; treat with selective serotonin reuptake inhibitors (SSRIs) and/or therapy
Postpartum blues — mild and self-limited, 50–80% incidence, resolves in less than 2 weeks
Postpartum anxiety — characterized by prominent worry and intrusive thoughts, not frank psychosis
Postpartum hypomania — insomnia and agitation in the early postpartum period can reflect hypomania, and postpartum mood elevation does signal bipolar risk, but by definition hypomania has no psychotic features; delusions about the baby and disorganized thinking place this in postpartum psychosis
Question 2ReproductiveMedium
A woman has severe depression, guilt, insomnia, and poor bonding 4 weeks after delivery. She denies hallucinations or intent to harm herself or the infant. Which of the following is the most appropriate treatment?
ABenzodiazepine monotherapy as needed
BInterpersonal psychotherapy
CPsychotherapy plus SSRI therapy
DReassurance with six-week follow-up
EElectroconvulsive therapy course
Reveal answer & full explanation
Correct answer: C — Psychotherapy plus SSRI therapy
ABenzodiazepine monotherapy as needed
BInterpersonal psychotherapy
CPsychotherapy plus SSRI therapy✓
DReassurance with six-week follow-up
EElectroconvulsive therapy course
Why Psychotherapy plus SSRI therapy is correct
Postpartum depression presenting with persistent depressed mood, guilt, insomnia, and impaired bonding warrants active treatment.
Combining psychotherapy with an SSRI is standard, choosing an agent compatible with breastfeeding such as sertraline.
Absence of psychosis or harm intent keeps this in the outpatient depression pathway.
Why the others are wrong
Interpersonal psychotherapy — Psychotherapy without medication is first-line only for mild to moderate postpartum depression; severe symptoms with impaired bonding call for combined treatment (undertreatment trap).
Reassurance with six-week follow-up — Symptoms this impairing at 4 weeks exceed baby blues, which resolve within two weeks of delivery, so deferring care another six weeks is inappropriate (minimization trap).
Benzodiazepine monotherapy as needed — Benzodiazepines treat neither the core depression nor bonding impairment and risk dependence and sedation while caring for an infant (wrong-drug-class trap).
Electroconvulsive therapy course — the severity of her symptoms can suggest ECT, but it is generally reserved for postpartum depression with psychotic features, catatonia, high suicide risk, refusal to eat or drink, or failure of medication trials; an outpatient without psychosis or harm intent should start combined psychotherapy and an SSRI (overtreatment trap).
That's 2. Get 7,700+ more.
Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.
You've read your 2 free diagnosis previews. Create your free account to unlock the full Postpartum Depression and Postpartum Psychosis outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Multifactorial — abrupt drop in estrogen and progesterone after delivery, HPA-axis dysregulation, inflammatory cytokines, sleep deprivation, and genetic vulnerability. Postpartum psychosis is now considered closely related to bipolar disorder.
Clinical presentation
Symptoms
Depression: depressed mood, anhedonia, sleep/appetite changes, guilt, fatigue, poor concentration, suicidal ideation; may include obsessive thoughts of harming the baby (ego-dystonic, usually no intent to act)
Psychosis: rapid onset (often first 2 wk) of insomnia, irritability, mood swings, paranoia, hallucinations, delusions (often involving the infant), confusion, disorganization
Difficulty bonding with the infant; thoughts of self-harm or harming the infant
Primary psychotic disorder — Pre-existing schizophrenia; onset not specifically perinatal
Diagnostic workup
Diagnostic criteria
DSM-5-TR: major depressive episode with peripartum-onset specifier (onset during pregnancy or within 4 weeks postpartum; in practice screening covers up to 12 mo). Edinburgh Postnatal Depression Scale (EPDS, cutoff >=10) or PHQ-9 used for screening. Postpartum psychosis: criteria for brief psychotic disorder or bipolar/mood disorder with psychotic features and peripartum onset.
Labs
TSH and free T4 (postpartum thyroiditis)
CBC (anemia), CMP, vitamin D, vitamin B12
Toxicology if clinically indicated
Imaging
Neuroimaging if focal findings, severe headache, or first psychotic episode without explanation
Diagnostic algorithm
Condition
Onset
Duration
Key Features
Treatment
Postpartum blues
Day 2-5
<=2 weeks
Mild lability, tearfulness; no impairment
Reassurance, support, observation
Postpartum depression
Within 12 mo (often <3 mo)
>=2 weeks
Depressed mood, anhedonia, +/- intrusive thoughts
Psychotherapy +/- SSRI (sertraline); zuranolone in severe
Psychiatric emergency, admit, mood stabilizer + antipsychotic, ECT for refractory
Spectrum of postpartum mood disorders.
Treatment
First-line
Universal screening for perinatal depression at the initial OB visit, at least once during pregnancy, at the postpartum visit, and at well-child visits (USPSTF, ACOG, AAP); USPSTF also recommends referring at-risk pregnant and postpartum patients to counseling (CBT or interpersonal therapy) to prevent perinatal depression (Grade B)
Moderate-severe PPD or with suicidal ideation: SSRI (sertraline preferred — low breast milk transfer; paroxetine alternative) + psychotherapy + safety planning
Oral zuranolone 50 mg nightly with a fat-containing meal for 14 days: FDA-approved (2023) neuroactive steroid GABA-A modulator for postpartum depression with rapid onset; boxed warning for impaired driving (no driving for at least 12 h after each dose). IV brexanolone (60 h infusion) is no longer marketed in the US (FDA approval withdrawn in 2025).
Postpartum psychosis is a psychiatric emergency: immediate hospitalization, do not leave mother alone with infant, evaluate for harm to self or infant; mood stabilizer (lithium; avoid valproate in people of reproductive potential because of teratogenicity), atypical antipsychotic (olanzapine, risperidone), ECT considered for refractory or severe cases
Breastfeeding considerations
Sertraline and paroxetine have the lowest infant exposure
Fluoxetine has a long half-life and active metabolites — relatively higher infant levels
Lithium can be used during breastfeeding with infant monitoring (serum lithium level, TSH, creatinine); valproate has low milk transfer but is avoided in people of reproductive potential because of teratogenicity
Most antipsychotics (olanzapine, quetiapine, risperidone) compatible with breastfeeding
Second-line / adjunct
SNRI (venlafaxine, duloxetine), bupropion, mirtazapine for partial response or specific symptom profile
ECT for severe, refractory, or psychotic depression
Social support, partner involvement, sleep optimization
Complications
Maternal suicide (leading cause of postpartum maternal mortality in many high-income countries)
Infanticide (rare, predominantly in postpartum psychosis)
Family disruption, marital discord, recurrent depression
PANCE pearls
Postpartum blues do not require treatment but warrant follow-up — persistence beyond 2 weeks or impairment should prompt reassessment for PPD.
Postpartum psychosis is a psychiatric emergency. Up to 4% commit infanticide and 5% suicide if untreated — admit and never leave mother alone with infant until stabilized.
Sertraline is the preferred SSRI in lactating mothers given its minimal breast milk transfer.
Always check TSH in postpartum mood disorders — postpartum thyroiditis is common and treatable.
Bipolar disorder must be considered before starting an SSRI alone — unrecognized bipolar postpartum psychosis can be precipitated or worsened by monotherapy antidepressants.
References
ACOG CPG No. 4 — ACOG Clinical Practice Guideline No. 4: Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum (Obstet Gynecol 2023;141:1232-61)
USPSTF 2019 — USPSTF: Interventions to Prevent Perinatal Depression (Grade B)
FDA Zuranolone — FDA approval of Zurzuvae (zuranolone), first oral treatment for postpartum depression (Aug 2023); approval of Zulresso (brexanolone) withdrawn effective Apr 14, 2025 (Fed Regist 2025;90:12162-3)
ACOG CPG No. 5 — ACOG Clinical Practice Guideline No. 5: Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum (Obstet Gynecol 2023;141:1262-88)
USPSTF 2023 — USPSTF: Screening for Depression and Suicide Risk in Adults, including pregnant and postpartum persons (JAMA 2023;329:2057-67)
Practice Reproductive questions on FirstPassPA
Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.